TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 88 filers reported holding TANGO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $10,196,034 | +8.1% | 1,188,349 | 0.0% | 0.78% | +11.6% |
| Q1 2024 | $9,435,491 | -19.8% | 1,188,349 | 0.0% | 0.70% | -39.3% |
| Q4 2023 | $11,764,655 | -20.1% | 1,188,349 | -9.1% | 1.16% | -29.1% |
| Q3 2023 | $14,720,750 | +343.4% | 1,307,349 | +30.7% | 1.63% | +461.7% |
| Q2 2023 | $3,320,000 | -15.9% | 1,000,000 | 0.0% | 0.29% | -10.8% |
| Q1 2023 | $3,950,000 | -75.1% | 1,000,000 | -71.4% | 0.32% | -75.8% |
| Q2 2022 | $15,855,000 | -61.9% | 3,500,000 | -36.2% | 1.34% | -28.1% |
| Q1 2022 | $41,598,000 | -30.7% | 5,487,910 | 0.0% | 1.86% | +10.2% |
| Q4 2021 | $60,038,000 | -15.4% | 5,487,910 | 0.0% | 1.69% | -4.2% |
| Q3 2021 | $70,959,000 | – | 5,487,910 | – | 1.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,201,475 | $164,748,656 | 81.48% |
| Mass General Brigham, Inc | 354,192 | $3,038,967 | 14.80% |
| Nextech Invest Ltd. | 5,533,980 | $47,481,548 | 7.99% |
| Boxer Capital, LLC | 8,198,642 | $70,344,348 | 3.70% |
| EcoR1 Capital, LLC | 13,330,736 | $114,377,715 | 3.50% |
| Braslyn Ltd. | 26,961 | $231,325 | 2.77% |
| Bain Capital Life Sciences Investors, LLC | 2,892,663 | $24,819,049 | 2.72% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 115,571 | $991,599 | 1.25% |
| Samsara BioCapital, LLC | 630,000 | $5,405,400 | 1.13% |
| Southpoint Capital Advisors LP | 5,276,699 | $45,274,077 | 1.13% |